Molecular & Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology.
Precision System Science Co., Ltd.
J Vis Exp. 2024 Jun 28(208). doi: 10.3791/66571.
Protein glycosylation, a critical post-translational modification, influences the stability, efficacy, and immunogenicity of recombinant proteins, including biopharmaceuticals. Glycan structures exhibit significant heterogeneity, varying with production cell types, culture conditions, and purification methods. Consequently, monitoring and evaluating the glycan structures of recombinant proteins is vital, particularly in biopharmaceutical production. The lectin microarray, a technique complementary to mass spectrometry, boasts high sensitivity and ease of use. However, it typically requires more than a day to yield results. To adapt it to non-glycoscience research or drug product process development, an automated, high-throughput alternative is needed. Therefore, the world's first fully automated lectin-based glycan profiling system was developed, utilizing the "bead array in a single tip (BIST)" technology concept. This system allows for the preparation and storage of lectin-immobilized beads in units of 1,000, with customizable parallel insertion orders for various purposes. This article presents a practical protocol for research involving "glyco-qualified" recombinant proteins. After testing their reactivity against 12 polyacrylamide-glycan conjugates, 15 lectins were selected to increase the system's versatility. In addition, the sample labeling process was optimized by switching from Cy3 to biotin, reducing the overall processing time by 30 min. For immediate data qualification, lectin-binding signals are displayed as a dotcode on the top monitor. The system's reliability was confirmed through day-to-day reproducibility tests, repeatability tests, and long-term storage tests, with a coefficient of variation of <10%. This user-friendly and rapid glyco-analyzer has potential applications in the quality monitoring of endogenous glycoproteins for biomarker evaluation and validation. This method facilitates analysis for those new to glycoscience, thereby broadening its practical utility.
蛋白质糖基化是一种重要的翻译后修饰,影响重组蛋白(包括生物制药)的稳定性、效力和免疫原性。糖基结构表现出显著的异质性,随生产细胞类型、培养条件和纯化方法的不同而变化。因此,监测和评估重组蛋白的糖基结构至关重要,特别是在生物制药生产中。凝集素微阵列是一种与质谱互补的技术,具有高灵敏度和易用性。然而,它通常需要一天以上的时间才能得出结果。为了将其应用于非糖科学研究或药物产品工艺开发,需要一种自动化、高通量的替代方法。因此,开发了世界上第一个完全自动化的基于凝集素的糖基谱分析系统,利用“单个尖端的珠阵列(BIST)”技术概念。该系统允许以 1000 个单位的数量制备和储存固定有凝集素的珠,并可根据各种目的自定义并行插入顺序。本文介绍了一种用于研究“糖合格”重组蛋白的实用方案。在测试了它们对 12 种聚丙烯酰胺-聚糖缀合物的反应性后,选择了 15 种凝集素来增加系统的通用性。此外,通过从 Cy3 切换到生物素,优化了样品标记过程,使总处理时间缩短了 30 分钟。为了即时数据定性,将凝集素结合信号显示为顶监视器上的点码。通过日常重现性测试、重复性测试和长期存储测试,确认了该系统的可靠性,变异系数<10%。这种用户友好且快速的糖分析仪具有在质量监测内源性糖蛋白用于生物标志物评估和验证方面的潜在应用。这种方法便于那些新涉足糖科学领域的人进行分析,从而扩大了其实用性。